354 related articles for article (PubMed ID: 37344125)
1. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.
Chavda V; Zajac KK; Gunn JL; Balar P; Khadela A; Vaghela D; Soni S; Ashby CR; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1821. PubMed ID: 37344125
[TBL] [Abstract][Full Text] [Related]
2. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
5. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
7. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: recent trends in Japan.
Kiyosawa K; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Gad A; Tanaka E
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S17-26. PubMed ID: 15508082
[TBL] [Abstract][Full Text] [Related]
10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
11. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
12. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of hepatocellular carcinoma in Asia.
Goh GB; Chang PE; Tan CK
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
[TBL] [Abstract][Full Text] [Related]
15. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
16. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
19. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
Nalpas B; Driss F; Pol S; Hamelin B; Housset C; Brechot C; Berthelot P
J Hepatol; 1991 Jan; 12(1):70-4. PubMed ID: 1848875
[TBL] [Abstract][Full Text] [Related]
20. A comparison of patients with hepatitis B- or hepatitis C-based advanced-stage hepatocellular carcinoma.
Carr BI; Guerra V; Steel JL; Lu SN
Semin Oncol; 2015 Apr; 42(2):309-15. PubMed ID: 25843735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
